Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria antigens and MHC restriction.

F Sinigaglia1, M Guttinger, P Romagnoli

  • 1Central Research Unit, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

Immunology Letters
|August 1, 1990
PubMed
Summary

Malaria vaccine development may be feasible as T cell determinants from malaria proteins bind to many human MHC class II molecules. This broad binding suggests MHC restriction may not hinder subunit vaccine progress.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indoor air quality at life and work environments in Rome, Italy.

Environmental science and pollution research international·2015
Same author

Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease.

Diabetes & metabolism·2015
Same author

Immunohistochemical analysis of dendritic cells in skin lesions: correlations with survival time.

Forensic science international·2014
Same author

Human platelets express authentic CB₁ and CB₂ receptors.

Current neurovascular research·2010
Same author

Lysophosphatidic acid induces protein tyrosine phosphorylation in the absence of phospholipase C activation in human platelets.

Platelets·2010
Same author

Tacrolimus causes reduced GLI1 expression and phenotypic changes in the TE 354.T basal cell carcinoma cell line.

Journal of dermatological science·2008

Area of Science:

  • Immunology
  • Vaccinology
  • Parasitology

Background:

  • Developing a malaria vaccine faces challenges, including immune system responses restricted by human leukocyte antigen (HLA) class II molecules.
  • Understanding T cell responses to malaria antigens is crucial for effective vaccine design.

Purpose of the Study:

  • To investigate the T cell recognition of malaria CS protein and 190L polypeptide.
  • To assess the binding capabilities of identified epitopes with diverse human MHC class II molecules.

Main Methods:

  • Analysis of T cell determinants from malaria CS protein.
  • Identification and binding analysis of epitopes from the 190L polypeptide (p190 merozoite surface protein).
  • Evaluation of epitope binding across various HLA class II isotypes and alleles.

Main Results:

  • At least one T cell determinant in the malaria CS protein binds to most human MHC class II molecules.
  • Several epitopes from the 190L polypeptide are recognized by T cells and bind to multiple HLA class II variants.
  • The identified peptides demonstrate broad binding potential to different allelic forms of MHC class II.

Conclusions:

  • Immune unresponsiveness due to MHC restriction may not be a significant barrier to developing a malaria subunit vaccine.
  • The broad T cell recognition and MHC class II binding of malaria epitopes support the potential for a broadly applicable malaria vaccine.

Related Experiment Videos